Literature DB >> 16044171

Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations.

T Li1, F Zhang, X Liu, X Sun, P C Sham, C Crombie, X Ma, Q Wang, H Meng, W Deng, P Yates, X Hu, N Walker, R M Murray, D St Clair, D A Collier.   

Abstract

The dystrobrevin-binding protein 1 (DTNBP1) gene on chromosome 6p has emerged as a potential susceptibility gene for schizophrenia. Although a number of attempts to replicate the original association finding have been successful, they have not identified any obvious pathogenic variants or a single at risk haplotype common to all populations studied. In the present study we attempted further replication in an independent sample of 638 nuclear families from the Han Chinese population of Sichuan Province, SW China. We also examined 580 Scottish schizophrenic cases and 620 controls. We genotyped 10 single-nucleotide polymorphisms (SNPs) in DTNBP1 that were used in the original report of association, plus rs2619538 (SNP 'A') in the putative promoter region, which has also been associated with schizophrenia. In the Chinese trios we found that two SNPs (P1635 and P1765) were significantly overtransmitted, but with alleles opposite to those reported in the original studies. SNPs P1757 and P1765 formed a common haplotype, which also showed significant overtransmission. In the Scottish cases and controls, no individual markers were significantly associated with schizophrenia. A single haplotype, which included rs2619538 and P1583, and one rare haplotype, composed of P1320 and P1757, were significantly associated with schizophrenia, but no previously reported haplotypes were associated. Based on the data from the Chinese population, our results provide statistical support for DTNBP1 as a susceptibility gene for schizophrenia, albeit with haplotypes different from those of the original study. However, our lack of replication in the Scottish samples also indicates that caution is warranted when evaluating the robustness of the evidence for DTNBP1 as genetic risk factor for schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044171     DOI: 10.1038/sj.mp.4001718

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  16 in total

1.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

Review 2.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

Review 3.  [Correlations between risk gene variants for schizophrenia and brain structure anomalies].

Authors:  T Nickl-Jockschat; M Rietschel; T Kircher
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

4.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

5.  IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.

Authors:  Kathrin S Michelsen; Lisa S Thomas; Kent D Taylor; Qi T Yu; Ling Mei; Carol J Landers; Carrie Derkowski; Dermot P B McGovern; Jerome I Rotter; Stephan R Targan
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

6.  Whole genome association study in a homogenous population in Shandong peninsula of China reveals JARID2 as a susceptibility gene for schizophrenia.

Authors:  Yang Liu; Gang Chen; Nadine Norton; Wenmin Liu; Haining Zhu; Peng Zhou; Meng Luan; Shulin Yang; Xing Chen; Liam Carroll; Nigel M Williams; Michael C O'Donovan; George Kirov; Michael J Owen
Journal:  J Biomed Biotechnol       Date:  2009-10-27

7.  No association of dysbindin with symptom factors of schizophrenia in an Irish case-control sample.

Authors:  Sarah E Bergen; Ayman H Fanous; Po-Hsiu Kuo; Brandon K Wormley; F Anthony O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

8.  The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.

Authors:  Brien Riley; Po-Hsiu Kuo; Brion S Maher; Ayman H Fanous; Jingchun Sun; Brandon Wormley; F Anthony O'Neill; Dermot Walsh; Zhongming Zhao; Kenneth S Kendler
Journal:  Schizophr Res       Date:  2009-10-02       Impact factor: 4.939

9.  Replication of association between schizophrenia and chromosome 6p21-6p22.1 polymorphisms in Chinese Han population.

Authors:  Yang Zhang; Tianlan Lu; Hao Yan; Yanyan Ruan; Lifang Wang; Dai Zhang; Weihua Yue; Lin Lu
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 10.  Nature and nurture in neuropsychiatric genetics: where do we stand?

Authors:  Danielle M Dick; Brien Riley; Kenneth S Kendler
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.